Stock Events

Sinopharm 

HK$22.05
14
-HK$0.15-0.68% Wednesday 08:08

Statistics

Day High
22.55
Day Low
21.95
52W High
28.45
52W Low
17.44
Volume
4,790,463
Avg. Volume
5,039,442
Mkt Cap
63.51B
P/E Ratio
7.22
Dividend Yield
4.09%
Dividend
0.9

Upcoming

Dividends

4.09%Dividend Yield
10Y Growth
11.12%
5Y Growth
5.58%
3Y Growth
11.38%
1Y Growth
3.34%

Earnings

22MarExpected
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Next
0.46
0.86
1.27
1.67
Expected EPS
1.67
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1099.HK. It's not an investment recommendation.

About

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Show more...
CEO
Mr. Qingming Yu
Employees
113234
Country
Hong Kong
ISIN
CNE100000FN7
WKN
000A0N99U

Listings